Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 3
2014 4
2015 1
2016 2
2017 2
2018 2
2019 2
2020 2
2021 1
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
The Keap1-Nrf2 system and diabetes mellitus.
Uruno A, Yagishita Y, Yamamoto M. Uruno A, et al. Among authors: yagishita y. Arch Biochem Biophys. 2015 Jan 15;566:76-84. doi: 10.1016/j.abb.2014.12.012. Epub 2014 Dec 17. Arch Biochem Biophys. 2015. PMID: 25528168 Review.
Current Landscape of NRF2 Biomarkers in Clinical Trials.
Yagishita Y, Gatbonton-Schwager TN, McCallum ML, Kensler TW. Yagishita Y, et al. Antioxidants (Basel). 2020 Aug 7;9(8):716. doi: 10.3390/antiox9080716. Antioxidants (Basel). 2020. PMID: 32784785 Free PMC article. Review.
NRF2 and the Moirai: Life and Death Decisions on Cell Fates.
Yagishita Y, Chartoumpekis DV, Kensler TW, Wakabayashi N. Yagishita Y, et al. Antioxid Redox Signal. 2023 Mar;38(7-9):684-708. doi: 10.1089/ars.2022.0200. Epub 2023 Feb 22. Antioxid Redox Signal. 2023. PMID: 36509429 Free PMC article. Review.
A Point Mutation at C151 of Keap1 of Mice Abrogates NRF2 Signaling, Cytoprotection in Vitro, and Hepatoprotection in Vivo by Bardoxolone Methyl (CDDO-Me).
Gatbonton-Schwager T, Yagishita Y, Joshi T, Wakabayashi N, Srinivasan H, Suzuki T, Yamamoto M, Kensler TW. Gatbonton-Schwager T, et al. Among authors: yagishita y. Mol Pharmacol. 2023 Aug;104(2):51-61. doi: 10.1124/molpharm.123.000671. Epub 2023 May 15. Mol Pharmacol. 2023. PMID: 37188495 Free PMC article.
Nrf2-Mediated Regulation of Skeletal Muscle Glycogen Metabolism.
Uruno A, Yagishita Y, Katsuoka F, Kitajima Y, Nunomiya A, Nagatomi R, Pi J, Biswal SS, Yamamoto M. Uruno A, et al. Among authors: yagishita y. Mol Cell Biol. 2016 May 16;36(11):1655-72. doi: 10.1128/MCB.01095-15. Print 2016 Jun 1. Mol Cell Biol. 2016. PMID: 27044864 Free PMC article.
Nrf2 prevents Notch-induced insulin resistance and tumorigenesis in mice.
Chartoumpekis DV, Yagishita Y, Fazzari M, Palliyaguru DL, Rao UN, Zaravinos A, Khoo NK, Schopfer FJ, Weiss KR, Michalopoulos GK, Sipula I, O'Doherty RM, Kensler TW, Wakabayashi N. Chartoumpekis DV, et al. Among authors: yagishita y. JCI Insight. 2018 Mar 8;3(5):e97735. doi: 10.1172/jci.insight.97735. JCI Insight. 2018. PMID: 29515034 Free PMC article.
The Keap1-Nrf2 system prevents onset of diabetes mellitus.
Uruno A, Furusawa Y, Yagishita Y, Fukutomi T, Muramatsu H, Negishi T, Sugawara A, Kensler TW, Yamamoto M. Uruno A, et al. Among authors: yagishita y. Mol Cell Biol. 2013 Aug;33(15):2996-3010. doi: 10.1128/MCB.00225-13. Epub 2013 May 28. Mol Cell Biol. 2013. PMID: 23716596 Free PMC article.
22 results